Leerink Partners Initiates Coverage On Inspire Medical Systems with Market Perform Rating, Announces Price Target of $159
Portfolio Pulse from Benzinga Newsdesk
Leerink Partners analyst Mike Kratky has initiated coverage on Inspire Medical Systems (NYSE:INSP) with a Market Perform rating and a price target of $159.
October 16, 2023 | 3:50 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Inspire Medical Systems has been given a Market Perform rating by Leerink Partners, with a price target of $159.
The initiation of coverage by Leerink Partners with a Market Perform rating suggests that the firm sees INSP's stock performing at a level in line with the average return of the market. The price target of $159 indicates where they believe the stock will trade in the near future. This could influence investor sentiment and potentially impact the stock's price, but the neutral rating suggests no significant movement is expected in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100